Close Menu

More to Work With

The total number of human embryonic stem cell lines eligible for study with US federal fund is now 40, with the addition of 27 lines on Monday. According to The Scientist, NIH director Francis Collins, did, however, limit the use of these lines to diabetes-related pancreatic research, which was the consent forms stated the cells would be used to study. These lines were part of 28 submitted for approval by Harvard University.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Bloomberg reports AstraZeneca may conduct another study of its candidate SARS-CoV-2 vaccine after dosing error.

Moderna is applying for an Emergency Use Authorization for its coronavirus vaccine, according to the New York Times.

The National Health Service is to conduct a trial of Grail's blood-based screening test for cancer.

In PLOS this week: somatic mutation patterns of glioblastomas among Lebanese patients, phenome-wide study using UK Biobank data, and more.